一种用于检测急性心肌炎的新型循环microRNA
急性心肌炎诊断依赖侵入性心内膜心肌活检或并非普遍可及的心血管磁共振成像,亟需额外诊断手段。研究先在小鼠实验性自身免疫性心肌炎、心肌梗死及柯萨奇病毒诱导心肌炎中通过microRNA微阵列与qPCR筛选,锁定由Th17细胞合成的mmu-miR-721,并找到人同源物hsa-miR-Chr8:96。在四个独立心肌炎患者队列中验证该microRNA,其区分急性心肌炎与心肌梗死的ROC曲线下面积为0.927(95%CI 0.879–0.975),校正年龄、性别、射血分数和血清肌钙蛋白水平后仍保留诊断价值。作者认为该人同源物可用于区分心肌炎与心肌梗死。
要点
- hsa-miR-Chr8:96区分急性心肌炎与心肌梗死的ROC曲线下面积为0.927(95%CI 0.879–0.975)。
- 校正年龄、性别、射血分数和血清肌钙蛋白水平后,该microRNA仍保留诊断价值。
- mmu-miR-721由Th17细胞合成,存在于急性自身免疫性或病毒性心肌炎小鼠血浆,急性心肌梗死小鼠血浆中不存在。
- Th17细胞(以产生白细胞介素-17为特征)是心肌炎急性期心肌损伤的特征性表现。
- 人同源物hsa-miR-Chr8:96在四个独立心肌炎患者队列中被鉴定。
适用人群与场景
- 急性心肌炎患者与各种对照(包括心肌梗死患者)的血浆样本。
- 小鼠实验性自身免疫性心肌炎、心肌梗死及柯萨奇病毒诱导心肌炎模型。
研究设计与关键结果
- 研究先通过microRNA微阵列分析和定量聚合酶链反应(qPCR)在分选的CD4+ T细胞和Th17细胞中筛选,并在柯萨奇病毒诱导心肌炎小鼠样本中进行qPCR。
- mmu-miR-721由Th17细胞合成,存在于急性自身免疫性或病毒性心肌炎小鼠血浆,不存在于急性心肌梗死小鼠血浆。
- 人同源物hsa-miR-Chr8:96在四个独立心肌炎患者队列中被鉴定。
- 该microRNA区分急性心肌炎与心肌梗死的ROC曲线下面积为0.927(95%CI 0.879–0.975)。
- 校正年龄、性别、射血分数和血清肌钙蛋白水平后,该microRNA仍保留诊断价值。
证据类型、等级与局限
- 证据类型:基础实验(小鼠模型)加人体病例对照式验证研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,hsa-miR-Chr8:96可用于区分急性心肌炎患者与心肌梗死患者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The diagnosis of acute myocarditis typically requires either endomyocardial biopsy (which is invasive) or cardiovascular magnetic resonance imaging (which is not universally available). Additional approaches to diagnosis are desirable. We sought to identify a novel microRNA for the diagnosis of acute myocarditis.
METHODS: To identify a microRNA specific for myocarditis, we performed microRNA microarray analyses and quantitative polymerase-chain-reaction (qPCR) assays in sorted CD4+ T cells and type 17 helper T (Th17) cells after inducing experimental autoimmune myocarditis or myocardial infarction in mice. We also performed qPCR in samples from coxsackievirus-induced myocarditis in mice. We then identified the human homologue for this microRNA and compared its expression in plasma obtained from patients with acute myocarditis with the expression in various controls.
RESULTS: We confirmed that Th17 cells, which are characterized by the production of interleukin-17, are a characteristic feature of myocardial injury in the acute phase of myocarditis. The microRNA mmu-miR-721 was synthesized by Th17 cells and was present in the plasma of mice with acute autoimmune or viral myocarditis but not in those with acute myocardial infarction. The human homologue, designated hsa-miR-Chr8:96, was identified in four independent cohorts of patients with myocarditis. The area under the receiver-operating-characteristic curve for this novel microRNA for distinguishing patients with acute myocarditis from those with myocardial infarction was 0.927 (95% confidence interval, 0.879 to 0.975). The microRNA retained its diagnostic value in models after adjustment for age, sex, ejection fraction, and serum troponin level.
CONCLUSIONS: After identifying a novel microRNA in mice and humans with myocarditis, we found that the human homologue (hsa-miR-Chr8:96) could be used to distinguish patients with myocarditis from those with myocardial infarction. (Funded by the Spanish Ministry of Science and Innovation and others.).
参考来源
- Blanco-Domínguez R, Sánchez-Díaz R, de la Fuente H, et al. A Novel Circulating MicroRNA for the Detection of Acute Myocarditis. N Engl J Med. 2021. PMID: 34042389. doi:10.1056/NEJMoa2003608
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。